About GtreeBNT
GtreeBNT is a publicly listed company based in Seongnam-si (South Korea) founded in 2000, and was acquired by HLB in September 2021. Therapies for brain cancer treatment are developed by GtreeBNT. The company has 95 employees. Its chief executive, as recorded, is Yang Won Suk. The company was acqui-hired. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.
Company details
GtreeBNT was established in 2000 in Seongnam-si, South Korea, within the biotechnology sector. Focus is placed on developing treatments for brain cancer, specifically glioblastomas. The lead candidate, OKN-007, is advanced in phase Ib clinical trials and has obtained orphan drug designation from the USFDA. This therapy is designed to protect neural tissue and reduce necrosis in brain cells through the removal of reactive oxygen species and inhibition of endoglucosamine-6-sulfatase.
- Headquarters Seongnam-si, South Korea
- Employees 95
- Stage Public
- SectorsHealthcare
- Website gtreebnt.com
- Acquired by HLB (Sep 2021)
- Legal Name Hlb Therapeutics Co., Ltd.
Funding Insights of GtreeBNT
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of GtreeBNT with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2015 | Post-IPO | – | – |
2 investors in total: 2 institutional.
Investors in GtreeBNT
GtreeBNT has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HLB and E&Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| eninvestment.co.kr | ||||
Marine composite materials are manufactured for industry applications. | 1985 | hlbkorea.com | Ulsan, South Korea |
Investor details for GtreeBNT
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GtreeBNT
1 people are tracked at GtreeBNT (1 in leadership); the tracked headcount is 95.
| Name | Role | Group |
|---|---|---|
Yang Won Suk | CEO | Leadership |
Complete people profiles for GtreeBNT
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of GtreeBNT
GtreeBNT is a publicly listed company on the KRX with ticker symbol 115450 in South Korea, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date26 Mar 2010
- Listed onKRX: 115450
- Listed entityHLB Therapeutics Co., Ltd.
- Exchange sectorDistribution services
- ISINKR7115450009
- Share price2,880.00 KRW (-3.36% on the day) · 2026-10-14
- Market capitalisation280,949,303,589.00 KRW
- EPS (diluted, trailing year)-204.45 KRW
- Volume (last session)363,932
Financials of GtreeBNT
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 69.56B KRW | -9.23B KRW | 1.04B KRW |
| 2024 | 54.93B KRW | -22.79B KRW | 467.9M KRW |
| 2023 | 52.59B KRW | -2.30B KRW | -389.3M KRW |
| 2022 | 42.40B KRW | -11.35B KRW | -5.84B KRW |
| 2021 | 43.59B KRW | -17.20B KRW | -9.39B KRW |
Detailed financial statements for GtreeBNT
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of GtreeBNT
4 dated milestones of GtreeBNT across 21 years, from founding to its latest funding, stage changes and deals.
- Founded GtreeBNT is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round.
- Exit Acquired by HLB.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gtreebnt
Complete news archive for GtreeBNT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GtreeBNT
GtreeBNT was founded in 2000 and raised its 1st funding round 15 years after it was founded.
GtreeBNT is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Yang Won Suk is the CEO of GtreeBNT, as recorded in our data.
GtreeBNT has 95 employees.
Annual revenue of GtreeBNT is $48.16M as on Dec 31, 2025.
GtreeBNT was established in 2000 in Seongnam-si, South Korea, within the biotechnology sector. Focus is placed on developing treatments for brain cancer, specifically glioblastomas. The lead candidate, OKN-007, is advanced in phase Ib clinical trials and has obtained orphan drug designation from the USFDA. This therapy is designed to protect neural tissue and reduce necrosis in brain cells through the removal of reactive oxygen species and inhibition of endoglucosamine-6-sulfatase.
Yes, GtreeBNT is publicly traded on KRX under the ticker symbol 115450.
GtreeBNT has 2 investors. Key investors include HLB, and E&Investment.
Yes. GtreeBNT was acquired by HLB in September 2021.